home / stock / trpxy / trpxy short
Short Information | SciSparc Ltd ADR (OTCMKTS:TRPXY)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 107,351 |
Total Actual Volume | 288,034 |
Short Trends | |
---|---|
Cover Days | 12 |
Short Days | 5 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 5,368 |
Average Short Percentage | 37.64% |
Is there a TRPXY Short Squeeze or Breakout about to happen?
See the TRPXY Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-09-2021 | $6 | $6.03 | $6.15 | $6 | 53,544 | 20,850 | 38.94% |
02-08-2021 | $5.8 | $6 | $6 | $5.8 | 28,649 | 15,602 | 54.46% |
02-05-2021 | $5.85 | $5.75 | $5.9 | $4.3 | 23,518 | 9,642 | 41% |
02-04-2021 | $5.5 | $5.85 | $5.9 | $5.5 | 20,656 | 4,486 | 21.72% |
02-03-2021 | $5 | $5.5 | $5.55 | $5 | 21,119 | 5,266 | 24.93% |
02-02-2021 | $5 | $4.9 | $5 | $4.9 | 12,182 | 3,356 | 27.55% |
02-01-2021 | $4.44 | $4.6 | $4.75 | $4.2 | 12,312 | 3,094 | 25.13% |
01-29-2021 | $4.45 | $4.5 | $4.5 | $4.4 | 3,186 | 1,015 | 31.86% |
01-28-2021 | $4.2 | $4.4 | $4.79 | $4.2 | 16,005 | 5,500 | 34.36% |
01-27-2021 | $4.27 | $4.24 | $4.49 | $3.9 | 25,584 | 8,726 | 34.11% |
01-26-2021 | $4.3 | $4.58 | $4.6 | $4.1 | 21,949 | 12,255 | 55.83% |
01-25-2021 | $3.96 | $4 | $4.3 | $3.5 | 22,831 | 4,128 | 18.08% |
01-21-2021 | $3.5 | $4.1 | $4.1 | $3.5 | 2,514 | 1,891 | 75.22% |
01-20-2021 | $3.66 | $3.5 | $4.1 | $3.5 | 6,454 | 6,189 | 95.89% |
01-19-2021 | $3.76 | $3.15 | $3.76 | $3.15 | 5,037 | 1,747 | 34.68% |
01-15-2021 | $3.34 | $3.15 | $3.76 | $3.15 | 2,177 | 1,168 | 53.65% |
01-14-2021 | $3.6 | $3.33 | $3.6 | $3.32 | 1,925 | 432 | 22.44% |
01-13-2021 | $3.6 | $3.589 | $3.75 | $3.589 | 2,031 | 303 | 14.92% |
01-12-2021 | $3.8 | $3.6 | $3.8 | $3.36 | 3,557 | 1,681 | 47.26% |
01-11-2021 | $3.6 | $3.46 | $3.6 | $3.45 | 2,804 | 20 | 0.71% |
News, Short Squeeze, Breakout and More Instantly...
SciSparc Ltd ADR Company Name:
TRPXY Stock Symbol:
OTCMKTS Market:
SciSparc Engages Procaps for Development and Production of CannAmide™ and its SCI-110 Product Candidate The companies will work together on next phase of development following successful phase IIa clinical study for Tourette Syndrome in 2018 and preparations for CannAmide...
SciSparc Initiates Commercial Production of its CannAmide™ Pills The Anti-Inflammatory, Chronic Pain Treatment Is Expected to Be Distributed In Pharmacies Across Canada PR Newswire TEL AVIV, Israel , Feb. 9, 2021 /PRNewswire/ -- SciSparc Ltd.(formerly ...
Therapix Biosciences Announces Name Change to SciSparc Ltd. PR Newswire TEL AVIV, Israel , Jan. 28, 2021 /PRNewswire/ -- SciSparc Ltd. (OTCQB: TRPXY), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatme...